Chi Y, Zheng X, Zhang Y, Shi F, et al. Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase â…¡ Trial. Clin Cancer Res 2023 Aug 18:CCR-22-3406. doi: 10.1158/1078-0432.CCR-22-3406.
PMID: 37594724